---
id: pyelonephritis-striated-nephrogram_170
category: radiology
tags: [pyelonephritis, striated-nephrogram, CT, kidney, UTI]
deck: Infectious Diseases
created: 2025-11-11
modified: 2025-11-11
---

## Pyelonephritis - Striated Nephrogram

**Q:** What are the characteristic CT and MRI findings of acute pyelonephritis including the striated nephrogram sign, and when is imaging indicated?

**A:**

## DEFINITION

**Acute Pyelonephritis:** **"Bacterial infection of renal parenchyma and collecting system"**

**CT Hallmark:** **Striated nephrogram** (wedge-shaped hypoenhancing areas radiating from papilla to cortex)

**Key Point:** **Striated nephrogram = hallmark of acute pyelonephritis**

---

## PATHOPHYSIOLOGY

**Ascending Infection (95% - Most Common):**
- **Bacteria ascend** from bladder → ureter → renal pelvis → parenchyma
- **Via tubules** (infection spreads along tubules)
- **Ureteral reflux** (vesicoureteral reflux facilitates ascent)

**Hematogenous (5%):**
- **Bacteremia** seeds kidney
- **S. aureus** (most common hematogenous organism)
- **Endocarditis** (septic emboli)

**Key Point:** **Ascending infection = 95%** (cystitis → pyelonephritis)

---

## WHEN IMAGING IS INDICATED

**Imaging NOT Routine for Uncomplicated Pyelonephritis:**

**Indications for CT (Complicated Pyelonephritis):**

**Mnemonic: "DIABETIC-PERSISTS-SEPTIC-URINARY-OBSTRUCTION"**

**D**iabetic patient (high risk for complications - emphysematous pyelonephritis)
**I**mmunocompromised (transplant, HIV, neutropenia)
**A**typical presentation (no improvement after 48-72 hours antibiotics)
**B**acteremia/sepsis (severe illness, septic shock)
**E**xclusive (rule out abscess, obstruction)
**T**ransplant kidney (assess for rejection vs infection)
**I**nadequate response (persistent fever >72 hours on antibiotics)
**C**omplicated UTI history (recurrent, stones, obstruction)

**P**ersistent fever (>72 hours on appropriate antibiotics)
**E**xamine for abscess (if suspicion)
**R**enal transplant (rule out rejection)
**S**eptic shock (severe illness)
**I**mmunocompromised
**S**uspected obstruction (hydronephrosis)
**T**raumatic (recent instrumentation - stent, nephrostomy)
**S**tone disease (suspected obstructing stone)

**S**epsis (severe illness, hypotension)
**E**xclude abscess (if not improving)
**P**ersistent symptoms (>72 hours antibiotics)
**T**ransplant kidney
**I**mmunocompromised
**C**omplicated anatomy (prior surgery, stones)

**U**rinary obstruction suspected (hydronephrosis, stone)
**R**ecurrent infections (rule out anatomic abnormality)
**I**nadequate response (clinical failure)
**N**eutropenic (immunocompromised)
**A**bscess suspected
**R**enal transplant
**Y**ielding no improvement (persistent fever)

**O**bstruction suspected (stone, mass, PUJ obstruction)
**B**acteremia (positive blood cultures)
**S**eptic shock
**T**ransplant
**R**ecurrent pyelonephritis
**U**nresponding (persistent fever >72 hours)
**C**omplicated (diabetes, immunocompromised)
**T**rauma/instrumentation (recent)
**I**nadequate clinical response
**O**ther complications (abscess, gas)
**N**eutropenia

**Key Point:** **Image if: Persistent fever >72 hours + diabetes + immunocompromised + sepsis + suspected obstruction**

---

## CT FINDINGS (Preferred Modality)

**CT = Gold Standard for Complicated Pyelonephritis**

**Advantages:**
- **Fast, widely available**
- **Detects complications** (abscess, obstruction, gas)
- **Evaluates stone disease**

**Hallmark: Striated Nephrogram (Wedge-Shaped Hypoenhancement)**

---

### **CT WITH CONTRAST (Nephrogenic Phase) FINDINGS:**

**Mnemonic: "STRIATED-WEDGE-PATCHY-PERINEPHRIC"**

**Striated Nephrogram (HALLMARK - 80-90%):**
- **Wedge-shaped hypoenhancing streaks** radiating from medulla to cortex
- **Alternating** areas of normal and decreased enhancement
- **Tubular distribution** (follows tubules, collecting ducts)
- **Mechanism:** Tubular obstruction (edema, inflammatory debris) → decreased perfusion

**S**triated nephrogram (HALLMARK)
**T**ubular distribution (radial streaks)
**R**adiating from papilla to cortex
**I**nflammation obstructs tubules
**A**lternating enhancement (normal + decreased)
**T**ubules obstructed
**E**dema and inflammatory debris
**D**ecreased perfusion

**W**edge-shaped (pyramidal, follows vascular territory)
**E**nhancement decreased (compared to normal parenchyma)
**D**istribution radial (from medulla outward)
**G**oes from papilla to cortex
**E**dema in tubules

**P**atchy hypoenhancement (focal or multifocal)
**A**reas of decreased perfusion
**T**ubular obstruction
**C**ortical involvement (may extend to capsule)
**H**eterogeneous enhancement
**Y**ielding striated appearance

**P**erinephric fat stranding (80-90%)
**E**dema (inflammatory)
**R**enal enlargement (swelling)
**I**nflamed kidney (edematous)
**N**ephric fascia thickening (Gerota fascia)
**E**nlarged kidney
**P**hlegmon (if extension beyond capsule)
**H**aziness (fat stranding)
**R**enal sinus fat stranding
**I**nflammation extends
**C**apsular thickening

**Additional Findings:**
- **Renal enlargement** (kidney swollen, edematous)
- **Perinephric fat stranding** (inflammation extends beyond capsule - 80-90%)
- **Thickened renal fascia** (Gerota fascia thickening)
- **Focal mass-like area** (focal pyelonephritis - lobar nephronia)
- **Hydronephrosis** (if obstructing stone or PUJ obstruction)

**Key Point:** **Striated nephrogram = wedge-shaped hypoenhancing streaks** from papilla to cortex (80-90%)

---

### **UNENHANCED CT:**

- **Enlarged kidney** (swelling)
- **Loss of renal sinus fat clarity** (fat stranding)
- **Perinephric fat stranding**
- **Cannot see striated nephrogram** (requires contrast)

**Key Point:** **Contrast essential** for striated nephrogram (characteristic finding)

---

## MRI FINDINGS

**MRI Characteristics:**

**T1:**
- **Hypointense areas** (edema, inflammation - low signal)
- **Focal or wedge-shaped** (follows tubular distribution)

**T2:**
- **Hyperintense areas** (edema - very bright)
- **Wedge-shaped** (from medulla to cortex)
- **Perinephric edema** (hyperintense fat stranding)

**Post-contrast T1 Fat-Saturated:**
- **Striated hypoenhancement** (same as CT - wedge-shaped)
- **Perinephric enhancement** (inflamed perinephric fat)

**DWI/ADC:**
- **DWI hyperintense** (restricted diffusion - inflammatory edema, purulent debris in tubules)
- **ADC variable** (mixed - edema facilitates, pus restricts)
- **Abscess:** DWI bright + ADC dark (restricted diffusion)

**Key Point:** **MRI less commonly used** (CT faster, more available for acute pyelonephritis)

---

## ULTRASOUND FINDINGS

**Findings (Often Normal in Uncomplicated Pyelonephritis):**
- **Renal enlargement** (swelling)
- **Loss of corticomedullary differentiation** (edema obscures normal architecture)
- **Focal hypoechoic areas** (edema)
- **Hydronephrosis** (if obstructing stone)

**Advantages:**
- **Bedside, no radiation** (pregnancy, children)
- **Detects hydronephrosis** (obstructing stone)

**Limitations:**
- **Insensitive for parenchymal inflammation** (often normal in acute pyelonephritis)
- **Cannot detect striated nephrogram**

**Key Point:** **US often normal** in uncomplicated pyelonephritis (CT superior for parenchymal changes)

---

## FOCAL PYELONEPHRITIS (Lobar Nephronia)

**Definition:** **"Focal bacterial nephritis, mass-like area of infection"**

**CT Findings:**
- **Focal mass-like hypoenhancing area** (wedge-shaped or rounded)
- **No liquefaction** (vs abscess has central non-enhancing fluid)
- **Ill-defined margins**
- **May mimic tumor** (renal cell carcinoma)

**Key Point:** **Focal pyelonephritis = mass-like** (no liquefaction, vs abscess has central fluid)

---

## EMPHYSEMATOUS PYELONEPHRITIS (EPN)

**Definition:** **"Severe necrotizing infection with gas formation in renal parenchyma"**

**Risk Factors:**
- **Diabetes mellitus** (90-95% have diabetes)
- **Urinary obstruction** (stone, PUJ obstruction)
- **Immunosuppression**

**CT Findings:**
- **Gas in renal parenchyma** (parenchymal gas - HALLMARK)
- **Gas in collecting system** (less severe)
- **Gas in perinephric space** (extension)
- **Renal necrosis** (non-enhancing parenchyma)
- **Abscess formation** (fluid + gas)

**Classification (Huang-Tseng):**
- **Class 1:** Gas in collecting system only (least severe)
- **Class 2:** Gas in renal parenchyma (no extension)
- **Class 3a:** Gas in perinephric space (extension beyond fascia)
- **Class 3b:** Gas in pararenal space (extends to psoas)
- **Class 4:** Bilateral EPN OR single kidney with EPN (worst prognosis)

**Organisms:**
- ***E. coli*** (70-80% - most common)
- **Klebsiella** (10-15%)
- **Proteus** (5-10%)
- **Anaerobes** (mixed)

**Treatment:**
- **Emergency nephrectomy** (if Class 3-4, severe, non-functioning kidney)
- **Percutaneous drainage + antibiotics** (if Class 1-2, stable patient, functioning kidney)
- **Medical therapy alone** rarely successful (<20%)

**Mortality:** 20-40% (even with treatment)

**Key Point:** **EPN = gas in parenchyma + diabetes (90%)** | **Mortality 20-40%** | **Nephrectomy often required**

---

## CLINICAL PRESENTATION

**Symptoms:**
- **Fever** (90-100%, high-grade, rigors)
- **Flank pain** (70-90%, unilateral)
- **Nausea/vomiting** (50-70%)
- **Dysuria** (40-60%)
- **Costovertebral angle tenderness** (90%)

**Key Point:** **Fever + flank pain + CVAT = pyelonephritis**

---

## LABS

**Urinalysis:**
- **Pyuria** (WBC >10/hpf - 90-100%)
- **Bacteriuria** (bacteria present)
- **WBC casts** (pathognomonic for pyelonephritis - 40-60%)
- **Hematuria** (30-50%)
- **Proteinuria** (mild)

**Blood:**
- **WBC elevated** (leukocytosis 70-90%)
- **CRP/ESR elevated** (90-95%)
- **Creatinine elevated** (if bilateral or single kidney)

**Urine Culture:**
- **Positive >100,000 CFU/mL** (90-95%)

**Blood Cultures:**
- **Positive 20-40%** (bacteremia)

**Key Point:** **WBC casts = pathognomonic** for pyelonephritis (40-60%)

---

## ORGANISMS

**Mnemonic: "E-COLI-KLEBSIELLA-ENTEROCOCCUS-PSEUDO"**

**Community-Acquired:**
- ***E. coli*** (70-80% - **most common**)
- ***Klebsiella*** (5-10%)
- ***Proteus mirabilis*** (5-10%)
- **Enterococcus** (5-10%)
- ***Staphylococcus saprophyticus*** (young women, 5%)

**Healthcare-Associated (Catheter, Instrumentation):**
- ***E. coli*** (still most common, but more resistant)
- ***Pseudomonas aeruginosa*** (10-20%)
- **Enterococcus** (VRE concern)
- **ESBL-producing Enterobacteriaceae** (Klebsiella, E. coli)

**Hematogenous:**
- ***Staphylococcus aureus*** (most common hematogenous)

**Key Point:** **E. coli = 70-80%** overall | **Pseudomonas = healthcare-associated**

---

## TREATMENT

**Antibiotics:**

**Uncomplicated Pyelonephritis (Outpatient if Stable):**
- **Fluoroquinolone** (if local resistance <10%):
  - **Ciprofloxacin** 500mg PO bid x 7 days
  - **Levofloxacin** 750mg PO daily x 5-7 days
- **OR Ceftriaxone** 1-2g IV x1 dose → **TMP-SMX** DS PO bid x 14 days (if susceptible)

**Complicated Pyelonephritis (Inpatient, IV Therapy):**

**Empiric (Until cultures):**
- **Ceftriaxone** 1-2g IV q24h
- **OR Cefepime** 1-2g IV q8-12h (if Pseudomonas risk)
- **OR Piperacillin-tazobactam** 4.5g IV q6h (if severe, Pseudomonas risk)

**Targeted (Based on culture):**
- **E. coli (susceptible):** Ceftriaxone
- **E. coli (ESBL):** Ertapenem or meropenem
- **Pseudomonas:** Cefepime or meropenem
- **Enterococcus:** Ampicillin (if susceptible) or vancomycin (if VRE)

**Duration:**
- **Uncomplicated:** 5-7 days (fluoroquinolone) or 14 days (TMP-SMX)
- **Complicated:** 10-14 days IV (or until clinically improved, then PO step-down)

**Key Point:** **Uncomplicated = fluoroquinolone x 5-7 days** | **Complicated = IV ceftriaxone x 10-14 days**

---

## PROGNOSIS

**Uncomplicated Pyelonephritis:**
- **Cure rate:** 90-95%
- **Recurrence:** 10-20%

**Complicated Pyelonephritis:**
- **Cure rate:** 70-85%
- **Mortality:** 5-10% (if sepsis, EPN)

**Emphysematous Pyelonephritis:**
- **Mortality:** 20-40% (even with treatment)

**Key Point:** **Uncomplicated = excellent prognosis** (90-95% cure) | **EPN = 20-40% mortality**

---

## COMPLICATIONS

**Mnemonic: "ABSCESS-SEPSIS-CHRONIC"**

**A**bscess (renal or perinephric - 5-10%)
**B**acteremia (20-40%)
**S**epsis (septic shock - 5-10%)
**C**hronic pyelonephritis (if recurrent)
**E**mphysematous pyelonephritis (if diabetes, gas-forming)
**S**car formation (renal cortical scarring)
**S**eptic shock (5-10%)

**S**epsis (bacteremia, septic shock)
**E**xtension (perinephric abscess, psoas abscess)
**P**apillary necrosis (if diabetes, NSAIDs, sickle cell)
**S**car (renal cortical scarring, chronic kidney disease)
**I**nfection spread (abscess, emphysematous)
**S**tenosis (renal artery, rare)

**C**hronic pyelonephritis (recurrent → scarring → CKD)
**H**ydronephrosis (if obstructing stone)
**R**ecurrence (10-20%)
**O**bstruction (if stone, PUJ)
**N**ecrosis (papillary necrosis, emphysematous)
**I**nadequate treatment (leads to abscess)
**C**ortical scarring (permanent)

**Key Point:** **Abscess (5-10%) most common complication** | **Sepsis (5-10%)** | **EPN (if diabetes)**

---

## DIFFERENTIAL DIAGNOSIS

**Other Causes of Striated Nephrogram:**

**Mnemonic: "INFECTION-ISCHEMIA-OBSTRUCTION-VENOUS"**

**Infection (Pyelonephritis):**
- **Striated nephrogram** + fever + pyuria + CVAT

**Ischemia (Renal Infarction):**
- **Wedge-shaped non-enhancing** (vs hypoenhancing pyelonephritis)
- **Acute onset pain**
- **Underlying embolic source** (atrial fibrillation, endocarditis)
- **No fever** (key differentiator)

**Obstruction (Acute Ureteral Obstruction):**
- **Striated nephrogram** (delayed excretion, tubular stasis)
- **Hydronephrosis** (dilated collecting system)
- **Obstructing stone** visible

**Venous Thrombosis (Renal Vein Thrombosis):**
- **Striated nephrogram**
- **Renal enlargement** (swelling)
- **Delayed nephrogram**
- **Thrombus in renal vein** (CT/MRI)

**Key Point:** **Pyelonephritis distinguished by fever + pyuria + CVAT** (vs infarct/obstruction/thrombosis)

---

**Clinical Pearls:**
- **Striated nephrogram = hallmark of pyelonephritis** (wedge-shaped hypoenhancing streaks, 80-90%)
- **Image if: Persistent fever >72 hours + diabetes + immunocompromised + sepsis + suspected obstruction**
- **Uncomplicated pyelonephritis = clinical diagnosis** (imaging NOT routine)
- **Striated nephrogram = tubular obstruction** (edema, inflammatory debris → decreased perfusion)
- **Perinephric fat stranding (80-90%)** + renal enlargement
- **WBC casts = pathognomonic** for pyelonephritis (40-60%)
- **E. coli = 70-80%** most common
- **Uncomplicated = fluoroquinolone x 5-7 days** (outpatient)
- **Complicated = IV ceftriaxone x 10-14 days** (inpatient)
- **EPN = gas in parenchyma + diabetes (90%)** | **Mortality 20-40%** | **Nephrectomy often required**
- **Focal pyelonephritis = mass-like** (no liquefaction, vs abscess has central fluid)
- **Abscess (5-10%) most common complication**

**Media:**

**Additional Resources:**
- **Radiopaedia.org:** Search "pyelonephritis," "striated nephrogram," "emphysematous pyelonephritis"
- **PMC:** Pyelonephritis imaging
- **IDSA Guidelines:** Urinary tract infections

**Sources:** [Radiopaedia - Pyelonephritis], [IDSA UTI Guidelines], [PMC - Renal Infections]
